Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.270
+0.040 (1.79%)
May 20, 2025, 4:00 PM - Market closed

Acelyrin Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
58.3865.4163.7813.553.56
Research & Development
212.16228.06481.3455.6338.23
Operating Expenses
270.55293.46545.1269.1841.79
Operating Income
-270.55-293.46-545.12-69.18-41.79
Interest & Investment Income
26.7231.2130.564.05-
Currency Exchange Gain (Loss)
----0.1-
Other Non Operating Income (Expenses)
9.6911.41-0.630.46-0.05
EBT Excluding Unusual Items
-234.14-250.85-515.19-64.77-41.84
Merger & Restructuring Charges
-21.39-21.39-10--
Gain (Loss) on Sale of Investments
18.4118.4110.5--
Gain (Loss) on Sale of Assets
-7---
Other Unusual Items
-31.4-1.4---
Pretax Income
-268.52-248.23-381.64-64.77-41.84
Net Income
-268.52-248.23-381.64-64.77-41.84
Net Income to Common
-268.52-248.23-381.64-64.77-41.84
Shares Outstanding (Basic)
100997021
Shares Outstanding (Diluted)
100997021
Shares Change (YoY)
11.59%41.35%4410.31%126.58%-
EPS (Basic)
-2.69-2.50-5.43-41.59-60.87
EPS (Diluted)
-2.69-2.50-5.43-41.59-60.87
Free Cash Flow
-286.77-305.17-172-61.52-4.98
Free Cash Flow Per Share
-2.87-3.07-2.45-39.50-7.24
EBITDA
-270.06-293.04-545.01--
D&A For EBITDA
0.480.420.12--
EBIT
-270.55-293.46-545.12-69.18-41.79
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q